Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial-Reference-Cited by-同舟云学术

Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial

Published:2017-03 Issue:3 Volume:5 Page:e324-e334
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Li Jing-Xin,Hou Li-Hua,Meng Fan-Yue,Wu Shi-Po,Hu Yue-Mei,Liang Qi,Chu Kai,Zhang Zhe,Xu Jun-Jie,Tang Rong,Wang Wen-Juan,Liu Pei,Hu Jia-Lei,Luo Li,Jiang Rong,Zhu Feng-Cai,Chen Wei

Funder

Chinese Ministry of Science and Technology and The National Health and Family Planning Commission

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial;Henao-Restrepo;Lancet,2015

2. Chimpanzee adenovirus vector Ebola vaccine—preliminary report;Ledgerwood;N Eng J Med,2015

3. Ebola Virus Disease Candidate Vaccines Under Evaluation in Clinical Trials;Martins;Expert Review of Vaccines,2016

4. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe—Preliminary Report;Agnandji;N Eng J Med,2015

5. Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study;De;Lancet Infect Dis,2015

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular vesicles-based “all-in-one” vaccine platform triggers mucosal immunity against respiratory viruses;Nano Today;2024-12

2. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

3. Recent Advances in Oral Vaccines for Animals;Veterinary Sciences;2024-08-05

4. The Immune System—A Double-Edged Sword for Adenovirus-Based Therapies;Viruses;2024-06-17

5. Application of Multivariate Data Analysis on Historical Recombinant Adenovirus Zoster Vaccine Production Data for Upstream Process Improvements;Journal of Pharmaceutical Sciences;2024-05